Investment Thesis
American Healthcare REIT demonstrates solid operational performance with 7.9% revenue growth and strong free cash flow generation of $294.4M, supported by a healthy 4.8x interest coverage ratio and conservative 0.30x debt-to-equity leverage. However, the 1.3% ROA and 2.1% ROE indicate weak capital efficiency, while declining net income (-1.4% YoY) despite revenue growth raises concerns about operational expense management and profitability sustainability.
AHR Strengths
- Strong free cash flow of $294.4M with 13.0% FCF margin provides reliable distribution capacity
- Conservative leverage at 0.30x debt-to-equity with comfortable 4.8x interest coverage ratio indicates financial stability
- Solid revenue growth of 7.9% YoY demonstrates market demand in healthcare real estate segment
AHR Risks
- Declining net income (-1.4% YoY) despite revenue growth suggests deteriorating operational profitability or rising expenses
- Very low return metrics (1.3% ROA, 2.1% ROE) indicate inefficient capital deployment and weak capital utilization
- Minimal net margin at 3.1% leaves limited buffer for operational challenges or interest rate shocks
Key Metrics to Watch
- Net income trend and margin expansion to confirm operational performance stabilization
- Return on assets and equity improvement through enhanced capital efficiency
- Debt-to-equity ratio and interest coverage maintenance as rates potentially remain elevated
AHR Financial Metrics
AHR Profitability Ratios
AHR Balance Sheet & Liquidity
AHR 5-Year Financial Trend
5-Year Trend Summary: American Healthcare REIT, Inc.'s revenue has grown significantly by 86% over the 5-year period, indicating strong business expansion. The most recent EPS of $-1.08 indicates the company is currently unprofitable.
AHR Growth Metrics (YoY)
AHR Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $476.8M | -$4.1M | $-0.03 |
| Q2 2025 | $458.0M | -$1.9M | $0.01 |
| Q1 2025 | $452.1M | -$3.9M | $-0.04 |
| Q3 2024 | $416.2M | -$4.1M | $-0.03 |
| Q2 2024 | $410.6M | -$1.9M | $0.01 |
| Q1 2024 | $408.6M | -$3.9M | $-0.04 |
| Q3 2023 | $368.3M | -$6.0M | $-0.09 |
| Q2 2023 | $326.2M | -$12.2M | $-0.19 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
AHR Capital Allocation
AHR SEC Filings
Access official SEC EDGAR filings for American Healthcare REIT, Inc. (CIK: 0001632970)